These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17314928)

  • 1. World Health Organization program for the selection and use of essential medicines.
    Reidenberg MM
    Clin Pharmacol Ther; 2007 Apr; 81(4):603-6. PubMed ID: 17314928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential medicines for the whole world.
    Reidenberg MM
    Clin Pharmacol Ther; 2007 Nov; 82(5):500-3. PubMed ID: 17952105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the selection and use of essential medicines decrease inappropriate drug use?
    Reidenberg MM
    Clin Pharmacol Ther; 2009 Jun; 85(6):581-3. PubMed ID: 19451911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?
    Logez SM; Hutin YJ; Holloway K; Gray R; Hogerzeil HV
    J Clin Pharmacol; 2004 Oct; 44(10):1106-13. PubMed ID: 15342611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2009; (958):1-242, back cover. PubMed ID: 20560299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to essential medicines for children: the world health organization's global response.
    Zucker H; Rägo L
    Clin Pharmacol Ther; 2007 Nov; 82(5):503-5. PubMed ID: 17952106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2008; (950):backcover, vii-174. PubMed ID: 18754303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selection and use of essential medicines.
    World Health Organ Tech Rep Ser; 2004; 920():1-127, back cover. PubMed ID: 15382605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model list of essential medicines).
    World Health Organ Tech Rep Ser; 2003; 914():i-vi, 1-126. PubMed ID: 12872478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Realities of paediatric pharmacotherapy in the developing world.
    Hoppu K; Sri Ranganathan S; Dodoo AN
    Arch Dis Child; 2011 Aug; 96(8):764-8. PubMed ID: 21441240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).
    World Health Organ Tech Rep Ser; 2006; (933):1-119, back cover. PubMed ID: 17566509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2007; (946):1-162, back cover. PubMed ID: 18309920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
    Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
    Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving availability and affordability of plasma-derived medicines.
    Cheraghali AM; Abolghasemi H
    Biologicals; 2010 Jan; 38(1):81-6. PubMed ID: 20137973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of essential drugs.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2000; 895():1-61. PubMed ID: 11286007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global aspects of drug development.
    Hoppu K; Hogerzeil HV
    Handb Exp Pharmacol; 2011; 205():353-72. PubMed ID: 21882121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibacterial paradox: essential drugs, effectiveness, and cost.
    Fasehun F
    Bull World Health Organ; 1999; 77(3):211-6. PubMed ID: 10212510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
    Lindenberg M; Kopp S; Dressman JB
    Eur J Pharm Biopharm; 2004 Sep; 58(2):265-78. PubMed ID: 15296954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.